Skip to main content

Table 3 Summary of adherence to mirabegron compared with antimuscarinics (all eligible patients; N = 1798)

From: A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain

 

Mirabegron

(N = 1169)

Antimuscarinics

(N = 629)

MPR-fixed

 Mean (SD)

38.69 (33.75)

25.88 (28.14)

 Adherenta, N (%)

257 (22.0)

69 (11.0)

MPR-variable

 Mean (SD)

97.65 (4.03)

98.03 (4.57)

 Adherenta, N (%)

1163 (99.5)

619 (98.4)

  1. MPR medical possession ratio, SD standard deviation
  2. aMPR of ≥80%
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us